Oncology. 7SE, 7NE, 8NE, 8SE, 8SA, Infusion Services, Radiation Oncology.
Oncology. The Parties acknowledge that cancer is the leading cause of death in New Hampshire and, by utilizing its combined resources, the System can deliver more comprehensive, convenient, and cost-effective care for cancer patients. D-HH, in partnership with the Xxxxxx School of Medicine at Dartmouth College, is home to the Xxxxxx Xxxxxx Cancer Center (“NCCC”) in Lebanon, one of only 50 National Cancer Institute-designated “Comprehensive Cancer Centers” in the nation, performing cutting edge basic and clinical research and providing high quality, multi-disciplinary clinical care across a broad range of specialties and sub-specialties. One of NCCC’s four regional sites is co-located on CMC’s campus in Manchester, where D-HH physicians collaborate with CMC to provide certain outpatient, infusion, and inpatient oncology services and other local cancer survivorship resources. The Parties agree to utilize their combined resources to expand existing cancer care capabilities and create new medical and surgical treatment options and wraparound services. For example, System synergies will enable patients to receive complex outpatient and pre- and post- operative transplant care locally while travelling to DHMC only for complex surgery and inpatient services. In southern New Hampshire, the System will supplement CMC’s existing breast and colorectal surgical oncology services by deploying providers of more complex surgical, and pre- and post-operative care for pulmonary, esophageal, colorectal, endocrine, gynecologic and hematologic cancer conditions, offering a more convenient, less costly alternative for patients who presently seek such treatment out-of-state. The System will capitalize on NCCC’s nationally renowned clinical and research infrastructure to export and standardize care protocols/pathways to ensure consistent care quality and patient safety regardless of the site of service. Significantly, the Combination will enable the System to offer wider access to advanced clinical trial opportunities for eligible patients, many of whom reside in the larger population centers of southern New Hampshire. As referenced in Section 5.3.4(c) below, the System will seek to enhance and develop cancer treatment services at HH and MCH (including initiating infusion services at HH) by deploying oncological specialists to those and other member hospitals, providing patients more convenient, less costly access to specialty care than is presently available in those communities. In orde...
